111 – 120 of 162
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Older men with low serum estradiol and high serum SHBG have an increased risk of fractures
(
- Contribution to journal › Article
-
Mark
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis : the GENOMOS study
(
- Contribution to journal › Article
- 2007
-
Mark
Residual lifetime risk of fractures in women and men
(
- Contribution to journal › Article
-
Mark
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
(
- Contribution to journal › Article
- 2006
-
Mark
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
(
- Contribution to journal › Article
-
Mark
Physical activity and its effect on bone in the short- and long- term perspective.
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
(
- Contribution to journal › Article
-
Mark
Costs and quality of life associated with osteoporosis-related fractures in Sweden
(
- Contribution to journal › Article
-
Mark
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men
(
- Contribution to journal › Debate/Note/Editorial